Shanghai Kaibao Pharmaceutical CO.,Ltd held its 1st Extraordinary General Meeting of 2023 on 22 December 2023, during which the following proposal(s) was/were approved: Election and nomination of non-independent directors, cumulative voting system applicable, Mu Jingwei, non-independent director: Zhou Yingbin, non-independent director, Jing Shuzhong, non-independent director, Liu Jianzhong, non-independent director, Ren Liwang, non-independent director, Zhao Ningbo, non-independent director. Election and nomination of independent directors, cumulative voting system applicable: Ye Zuguang, independent director, Li Zhenni, independent director, Ma Hong, independent director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.17 CNY | 0.00% | -1.75% | -7.22% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.22% | 892M | |
+34.35% | 705B | |
+29.39% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
-3.03% | 210B | |
+10.02% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- 300039 Stock
- News Shanghai Kaibao Pharmaceutical CO.,Ltd
- Shanghai Kaibao Pharmaceutical CO.,Ltd Announces Executive Changes